Sarissa Capital Management LP

GREENWICH, CT · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$153.2M2026 Q3
Positions10
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Sarissa Capital Management LP reported 10 positions worth $153.2M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: INVA (26.2%). Biggest move: reduce AMRN ($5.0M).

10 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 INVAInnoviva$40.1M26.18%1,890,604——-10.3%
▸ 2 IRWDIronwood Pharmaceuticals$36.5M23.82%9,188,635——+21.7%
▸ 3 AMRNAmarin Corp Plcuk$16.7M10.92%1,287,090——-6.8%
▸ 4 LNTHLantheus$16.6M10.85%166,919——+2.2%
▸ 5 NBIXNeurocrine Biosciences$16.5M10.79%116,533——+16.5%
▸ 6 CYTKCytokinetics$15.1M9.84%228,623——-19.3%
▸ 7 BHVNBiohaven$7.8M5.08%582,312———
▸ 8 REGNRegeneron Pharmaceuticals$3.2M2.07%4,190——+25.6%
▸ 9 VORVor Biopharma$484.6K0.32%25,399——-0.6%
▸ 10 BIIBBiogen$214.6K0.14%950——+11.4%

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Sarissa Capital Management LP hold as of Q3 2026?

Sarissa Capital Management LP reported 10 positions worth $153.2M in its Q3 2026 13F filing. Largest positions: INVA (26.2%), IRWD (23.8%), AMRN (10.9%), LNTH (10.8%) and NBIX (10.8%).

What did Sarissa Capital Management LP buy in Q3 2026?

Sarissa Capital Management LP opened or added to no positions in Q3 2026.

What did Sarissa Capital Management LP sell in Q3 2026?

Reduced: AMRN.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.